AMANDA BAUER: Open Payments
NPI 1053301317 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 88 payments from 36 companies in 2025. Trend: 2023 $1,083 · 2024 $624 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| PFIZER INC. | 8 | $136 |
| TerSera Therapeutics LLC | 4 | $110 |
| Astellas Pharma US Inc | 5 | $106 |
| Pharmacosmos Therapeutics Inc. | 4 | $89 |
| Genentech USA, Inc. | 4 | $83 |
| Janssen Biotech, Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
Products named: EPKINLY, Vyloy, IBRANCE, MONOFERRIC, Zoladex, Amtagvi, SCEMBLIX, Xermelo.
Industry payments across NE — which companies pay providers there.
